John A. Ward

Array ( [id] => 70827 [patent_doc_number] => 07754202 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-07-13 [patent_title] => 'Methods of controlling cell differentiation and growth using a fusion protein and a drug' [patent_app_type] => utility [patent_app_number] => 09/582916 [patent_app_country] => US [patent_app_date] => 1999-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 21847 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/754/07754202.pdf [firstpage_image] =>[orig_patent_app_number] => 09582916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6534616 [patent_doc_number] => 20020137030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'METHOD OF DETECTION OF NEOPLASTIC CELLS' [patent_app_type] => new [patent_app_number] => 09/225904 [patent_app_country] => US [patent_app_date] => 1999-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20647 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137030.pdf [firstpage_image] =>[orig_patent_app_number] => 09225904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1486810 [patent_doc_number] => 06428782 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Non-myeloablative tolerogenic treatment' [patent_app_type] => B1 [patent_app_number] => 09/222011 [patent_app_country] => US [patent_app_date] => 1998-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 24216 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/428/06428782.pdf [firstpage_image] =>[orig_patent_app_number] => 09222011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1235928 [patent_doc_number] => 06689757 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => 'Methods for vaccination and vaccines therefor' [patent_app_type] => B1 [patent_app_number] => 09/221050 [patent_app_country] => US [patent_app_date] => 1998-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 31 [patent_no_of_words] => 29283 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689757.pdf [firstpage_image] =>[orig_patent_app_number] => 09221050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1241105 [patent_doc_number] => 06682928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-27 [patent_title] => 'Cells expressing anti-Fc receptor binding components' [patent_app_type] => B2 [patent_app_number] => 09/203958 [patent_app_country] => US [patent_app_date] => 1998-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 22 [patent_no_of_words] => 19520 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/682/06682928.pdf [firstpage_image] =>[orig_patent_app_number] => 09203958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417350 [patent_doc_number] => 06514761 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Methods of using BCL-2 for the therapeutic treatment and prevention of diseases' [patent_app_type] => B1 [patent_app_number] => 09/188066 [patent_app_country] => US [patent_app_date] => 1998-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 14068 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514761.pdf [firstpage_image] =>[orig_patent_app_number] => 09188066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1414027 [patent_doc_number] => 06525029 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Method of inhibiting and immune response to a recombinant vector' [patent_app_type] => B1 [patent_app_number] => 09/182567 [patent_app_country] => US [patent_app_date] => 1998-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12049 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/525/06525029.pdf [firstpage_image] =>[orig_patent_app_number] => 09182567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1408115 [patent_doc_number] => 06528304 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Eukaryotic cells expressing at their surface at least an HLA-G isoform and their applications' [patent_app_type] => B1 [patent_app_number] => 09/147166 [patent_app_country] => US [patent_app_date] => 1998-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 27 [patent_no_of_words] => 8972 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528304.pdf [firstpage_image] =>[orig_patent_app_number] => 09147166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1483799 [patent_doc_number] => 06365151 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Cellular immunogens comprising cognate proto-oxogenes' [patent_app_type] => B1 [patent_app_number] => 09/167322 [patent_app_country] => US [patent_app_date] => 1998-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 16489 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365151.pdf [firstpage_image] =>[orig_patent_app_number] => 09167322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869461 [patent_doc_number] => 20030082150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'RECOMBINANT ADENOVIRAL VECTORS FOR HUMAN TUMOUR GENE THERAPY' [patent_app_type] => new [patent_app_number] => 09/125887 [patent_app_country] => US [patent_app_date] => 1998-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8417 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082150.pdf [firstpage_image] =>[orig_patent_app_number] => 09125887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1548438 [patent_doc_number] => 06399054 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Method for the production of activated marked tumor-specific T cells and use thereof in treatment of tumors' [patent_app_type] => B1 [patent_app_number] => 09/161998 [patent_app_country] => US [patent_app_date] => 1998-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 10456 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399054.pdf [firstpage_image] =>[orig_patent_app_number] => 09161998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645594 [patent_doc_number] => 06472375 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'DNA vaccine and methods for its use' [patent_app_type] => B1 [patent_app_number] => 09/144837 [patent_app_country] => US [patent_app_date] => 1998-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11061 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472375.pdf [firstpage_image] =>[orig_patent_app_number] => 09144837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6429088 [patent_doc_number] => 20020127205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'CELLS EXPRESSING IMMUNOREGULATORY MOLECULES AND USES THEREFOR' [patent_app_type] => new [patent_app_number] => 09/144006 [patent_app_country] => US [patent_app_date] => 1998-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28658 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20020127205.pdf [firstpage_image] =>[orig_patent_app_number] => 09144006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4311729 [patent_doc_number] => 06316420 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'DNA cytokine vaccines and use of same for protective immunity against multiple sclerosis' [patent_app_type] => 1 [patent_app_number] => 9/123485 [patent_app_country] => US [patent_app_date] => 1998-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 36 [patent_no_of_words] => 17157 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316420.pdf [firstpage_image] =>[orig_patent_app_number] => 123485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1548542 [patent_doc_number] => 06399074 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Live attenuated salmonella vaccines to control avian pathogens' [patent_app_type] => B1 [patent_app_number] => 09/122441 [patent_app_country] => US [patent_app_date] => 1998-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 13628 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399074.pdf [firstpage_image] =>[orig_patent_app_number] => 09122441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4314163 [patent_doc_number] => 06242426 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Induction of immune response to antigens expressed by recombinant adeno-associated virus' [patent_app_type] => 1 [patent_app_number] => 9/121162 [patent_app_country] => US [patent_app_date] => 1998-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21903 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242426.pdf [firstpage_image] =>[orig_patent_app_number] => 121162 [rel_patent_id] =>[rel_patent_doc_number] =>)